Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03721562 · ClinicalTrials.gov registry record
Antibiotic Resistance in Global Pediatric Oncology Centers
A clinical trial, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 560
- Enrollment target
NCT03721562 is a clinical trial that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 560 participants.
The verdict
NCT03721562 has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 560 participants
- Enrollment target
Study Summary
Antibiotic resistance is one of the major health threats facing global as well as domestic populations, however it is not well characterized in pediatric patients. Pediatric patients receiving cancer-directed therapy have several risk factors implicated in development of antibiotic resistance including multiple courses of antibiotics, repeated exposures to the hospital environment, indwelling devices and chemotherapy-related damage to mucosal barriers. The investigators propose to capitalize upon the unique position of St. Jude Global within the global pediatric oncology community by using its regional alliance network to describe the molecular epidemiology of antibiotic resistance in Gram-negative bacteria in this population. Primary Objectives 1. Describe the epidemiology and the phenotypic and previously determined molecular determinants of antimicrobial resistance in Gram-negative organisms isolated from pediatric diagnostic specimens in selected Central American and US sites with capacity to treat pediatric cancer 2. Utilize strain typing by whole genome sequencing to describe relatedness between organisms at participating sites
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 560 participants |
| Start Date | 2019-02-26 |
| Est. Completion | 2022-07-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03721562
The ClinicalTrials.gov registry entry for NCT03721562 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 560 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03721562 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03721562 about?
NCT03721562 is a clinical study titled "Antibiotic Resistance in Global Pediatric Oncology Centers". Antibiotic resistance is one of the major health threats facing global as well as domestic populations, however it is not well characterized in pediatric patients. Pediatric patients receiving cancer-directed therapy have several risk factors implicated in development of antibiotic resistance includ...
What is the current status of trial NCT03721562?
This trial is currently completed. The enrollment target is 560 participants. The study started on 2019-02-26. Estimated completion is 2022-07-29.
Who is sponsoring clinical trial NCT03721562?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.